Jean-Paul Clozel: "Il faut être prêt à se battre lorsqu'on pense que nos projets ont un sens" - rts.ch - Economie
![CAPTION ADDITION---Jean-Paul Clozel, CEO of biopharmaceutical company Actelion, speaks during a press conference in Allschwil, Switzerland, Thursday, February 22, 2007. Actelion announced its financial results for the full year 2006. With total CAPTION ADDITION---Jean-Paul Clozel, CEO of biopharmaceutical company Actelion, speaks during a press conference in Allschwil, Switzerland, Thursday, February 22, 2007. Actelion announced its financial results for the full year 2006. With total](https://c8.alamy.com/comp/2PBXWWB/caption-addition-jean-paul-clozel-ceo-of-biopharmaceutical-company-actelion-speaks-during-a-press-conference-in-allschwil-switzerland-thursday-february-22-2007-actelion-announced-its-financial-results-for-the-full-year-2006-with-total-net-revenue-of-9457-million-swiss-francs-usd-7644-and-operating-expenses-of-6775-million-swiss-francs-usd-5476-the-company-reported-operating-income-of-2682-million-swiss-francs-usd-2168-and-a-net-income-of-2411-million-swiss-francs-usd-1949-keystonegeorgios-kefalas-2PBXWWB.jpg)
CAPTION ADDITION---Jean-Paul Clozel, CEO of biopharmaceutical company Actelion, speaks during a press conference in Allschwil, Switzerland, Thursday, February 22, 2007. Actelion announced its financial results for the full year 2006. With total
![Biographie et publications | Jean-Paul Clozel - Innovation technologique Liliane Bettencourt | Collège de France Biographie et publications | Jean-Paul Clozel - Innovation technologique Liliane Bettencourt | Collège de France](https://www.college-de-france.fr/sites/default/files/styles/1_1_header_portrait_s/public/media/portrait/2022-07/Jean-Paul-Clozel.jpg?h=f0d95172&itok=x-K2x58a)
Biographie et publications | Jean-Paul Clozel - Innovation technologique Liliane Bettencourt | Collège de France
![Les secrets de management de Jean-Paul Clozel, l'homme qui a vendu sa biotech 30 milliards - Challenges Les secrets de management de Jean-Paul Clozel, l'homme qui a vendu sa biotech 30 milliards - Challenges](https://www.challenges.fr/assets/img/2018/04/11/cover-r4x3w1200-5acdf9bd5f246-img-4611.jpg)